Health & Biotech
Health Check: Imugene goes to the well after reporting more blood cancer ‘cures’
Scott Power: ASX health falls as Trump revives pharma import tariff threat; CSL ‘undervalued’
Neurizon on track to lift FDA clinical hold on ALS drug, eyes Healey trial in Q4 CY25
New Prescient leadership to drive PTX-100 development in rare blood cancer
Suffering from news overwhelm? Here are three tips to protect your peace
Health Check: For ASX biotechs, the business of America remains business
Imagion shares rally after positive FDA feedback on path to phase II breast cancer trial
Health Kick Podcast: Neurizon’s ALS push and trial plans
EZZ taps University of Sydney for bone growth supplement research
Health Check: POTUS puts drug tariffs back on agenda… another case of TACO?
Island fast tracks portfolio expansion with acquisition of Galidesivir for ‘high-priority threat’ viruses
EchoSolv enters Mayo’s test zone as it chases FDA approval
ASX biotechs join global race for cell therapy breakthroughs
Health Check: Dental supplier faces the hard tooth that amalgam fillings are on the way out
Health Kick Podcast: Filamon’s bold push against cancer and chronic disease
Argent starts EU-GMP cannabinoid supply for drug resistant epilepsy at Slovenia’s largest hospital
Dr Boreham’s Crucible: ASX newbie Tetratherix plays it slow and steady
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
